Table 1.
Compounds | Polarity | Q1→Q3 (m/z) | CE (V) | DP (V) | Dwell time (ms) | LLQ (ng/ml) |
---|---|---|---|---|---|---|
Prasugrel | + | 374→206 | 23 | 100 | 2 | 0.5 |
Prasugrel AM1 | + | 498→348 | 28 | 100 | 2 | 0.5 |
Prasugrel AM-d31 | + | 501→348 | 25 | 150 | 2 | 0.5 |
Midazolam | + | 326→291 | 37 | 165 | 2 | 0.1 |
Omeprazole | + | 346→198 | 19 | 66 | 2 | 0.5 |
Bupropion | + | 240→131 | 30 | 80 | 2 | 0.5 |
Flurbiprofen | + | 243→199 | 18 | 50 | 2 | 100 |
CE, collision energy; DP, declustering potential; LLQ, lower limit of quantification.
Compounds derivatized with 2-bromo-3-methoxyacetophenone (BMAP).